Keyphrases
Chronic Kidney Disease
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Acute Kidney Injury
100%
Renal Protection
100%
Glomerular Filtration Rate
44%
Glucose-lowering Drugs
22%
Sodium
22%
Nephroprotective Effect
22%
Metabolism
11%
Beneficial Effects
11%
Non-diabetic
11%
Type 2 Diabetic Patients
11%
Adenosine
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Macula
11%
Patients with Diabetes
11%
Diabetes Patients
11%
Oxygenation
11%
Renal Fibrosis
11%
Hypotension
11%
Without Diabetes
11%
Microalbuminuria
11%
Proteinuria
11%
Glomerulus
11%
Urinary Tract Infection
11%
Randomized Clinical Trial
11%
Weight Reduction
11%
Blood Pressure Lowering
11%
Renal Complications
11%
Tubuloglomerular Feedback
11%
Acute Renal Failure
11%
Real-world Observational Study
11%
Initial Dip
11%
Renal Inflammation
11%
Intraglomerular Pressure
11%
Narrative Assessment
11%
Class Effect
11%
Critical Narrative
11%
Nephron
11%
Glomerular Arterioles
11%
Hypovolemia
11%
Medicine and Dentistry
Sodium Glucose Cotransporter 2 Inhibitor
100%
Chronic Kidney Disease
100%
Renal Protection
100%
Glomerular Filtration Rate
44%
Diabetes
22%
Maturity Onset Diabetes of the Young
22%
Narrative
11%
Diabetes Mellitus
11%
Blood Pressure
11%
Arteriole
11%
Kidney Fibrosis
11%
Observational Study
11%
Proteinuria
11%
Microalbuminuria
11%
Glomerulus
11%
Urinary Tract Infection
11%
Randomized Clinical Trial
11%
Hypotension
11%
Nephron
11%
Acute Kidney Injury
11%
Adenosine
11%
Hypovolemia
11%
Nephritic Syndrome
11%